Millipore Sigma Vibrant Logo
Attention: We have moved. EMD Millipore products are no longer available for purchase on emdmillipore.com.Learn More


Press Releases
Back to Previous Page
 

MilliporeSigma News

Show
May 26, 2021
MilliporeSigma Accelerates Scale Up of Lipids to Meet Covid-19 Demand

To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, MilliporeSigma has launched a new, high-purity synthetic cholesterol product, nine months ahead of schedule.

20210526
May 20, 2021
MilliporeSigma Improves Lab Productivity Through Faster and More Sustainable Nucleic Acid Purification

MilliporeSigma introduced a new solution improving productivity in the lab through a more flexible and streamlined nucleic acid purification process — GenElute™-E Single Spin purification kits.

20210520
May 18, 2021
MilliporeSigma Announces VectorY as Winner of its Advance Biotech Grant

MilliporeSigma today announced that VectorY has been selected as the European winner of its 2021 Advance Biotech Grant Program.

20210518
May 04, 2021
MilliporeSigma Partners with Topco Scientific Co. to Increase Greener Manufacturing Materials Usage

MilliporeSigma today announced a partnership with Topco Scientific Co. (TSC), a leading semiconductor supplier in Taiwan, to increase the use of more sustainable materials for the electronics industry.

20210504
Mar 31, 2021
MilliporeSigma Establishes Collaboration Laboratory with Universitas Indonesia to Advance Life Science Research

MilliporeSigma today announced a strategic partnership with the Faculty of Mathematics and Natural Sciences, Universitas Indonesia (FMIPA-UI) to establish the first Collaboration Laboratory between the company and the university to advance life science research and innovation development in Indonesia.

20210331
Mar 17, 2021
MilliporeSigma Accelerates European Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies

MilliporeSigma will add a single-use assembly production unit at its Life Science Center in Molsheim, France.

20210317
Mar 16, 2021
MilliporeSigma Brings New Renewable Energy to the Grid through Virtual Power Purchase Agreement with Enel Green Power

As part of its ongoing commitment to renewable energy, MilliporeSigma has signed a 12-year, off-site, virtual power purchase agreement with Enel Green Power for the construction of a future wind and storage project in Texas.

20210316
Feb 25, 2021
MilliporeSigma to Manufacture Next-Generation Biotherapeutics for Alteogen

MilliporeSigma today announced an agreement with Alteogen, Inc., of South Korea, providing late-stage CDMO services through MilliporeSigma BioReliance® End-to-End Solutions.

20210225
Feb 15, 2021
MilliporeSigma Enhances Design for Sustainability Framework, Offers Customers Data-Driven Insights for Greener Solutions

MilliporeSigma today launched an enhanced Design for Sustainability (DfS) framework, a unique approach to holistically integrate sustainability into Life Science products, systems and services.

20210215
Feb 04, 2021
MilliporeSigma Continues Commitment to Science Education and Equity with Leading Non-Profits Around the World

MilliporeSigma today announced seven expanded partnerships with leading nonprofit organizations across the world.

20210204
Jan 07, 2021
MilliporeSigma Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics

MilliporeSigma today announced the acquisition of AmpTec, a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO).

20210107
Dec 07, 2020
MilliporeSigma Expands Production Capacities

MilliporeSigma today announced the broadening of its manufacturing footprint with a combined $47 million investment at its production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire.

20201207
Nov 20, 2020
Massachusetts-based Businesses of Merck KGaA, Darmstadt, Germany named to The Boston Globe’s ‘Top Places to Work’ List

Merck KGaA, Darmstadt, Germany, today announced that its Massachusetts-based businesses, MilliporeSigma, EMD Serono and EMD Performance Materials, have again been named to The Boston Globe’s annual “Top Places to Work 2020” list.

20201120
Nov 07, 2020
MilliporeSigma and Transcenta Collaborate to Advance Continuous Biomanufacturing, Make the ‘Facility of the Future’ a Reality

MilliporeSigma and Transcenta, a global biotherapeutics company, have announced a strategic technology collaboration to implement continuous manufacturing for protein therapeutics.

20201107
Nov 06, 2020
MilliporeSigma to Collaborate with Donghao Lansheng to Pilot New Import Policy in China

MilliporeSigma today announced the signing of a Letter of Intent with Donghao Lansheng (Group) Co., Ltd.

20201106
Nov 10, 2020
MilliporeSigma’s Latest Technologies Earn Industry Recognition for Accelerating Bioprocessing 4.0

MilliporeSigma today announced that its first-to-market Blazar™ platform from the BioReliance® portfolio has won R&D 100 and CPhI Awards for its ability to reduce testing times by up to 80 percent.

20201110
Oct 29, 2020
MilliporeSigma Collaborates with Mammoth Biosciences to Scale New SARS-CoV-2 Test

MilliporeSigma today announced a collaboration with Mammoth Biosciences Inc., of South San Francisco, California, for the development, scale-up and commercial production of Mammoth’s CRISPR-based SARS CoV-2 diagnostic test.

20201029
Oct 19, 2020
MilliporeSigma Awards Grant to Combined Therapeutics for its Nucleic Acid Platform That, with Virotherapy, Targets Liver Cancer

MilliporeSigma today announced that Combined Therapeutics Inc., Cambridge, Massachusetts, USA, has been selected as the North American winner of its 2020 Advance Biotech Grant Program.

20201019
Oct 13, 2020
MilliporeSigma New VirusExpress™ Platform Speeds Development of Cell and Gene Therapies

MilliporeSigma has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress™ Lentiviral Production Platform.

20201013
Oct 12, 2020
MilliporeSigma Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA

MilliporeSigma today announced that it has signed agreements licensing its CRISPR technology to two companies — PanCELLa, a cell therapy firm based in Toronto, Canada and Takara Bio USA, Inc., a biotechnology company based in Mountain View, California, USA.

20201012
Oct 08, 2020
MilliporeSigma Celebrates Topping-Out Ceremony for New Membrane Production Plant

MilliporeSigma today celebrated the topping-out ceremony for its new membrane production plant in Darmstadt, Germany.

20201008
Oct 08, 2020
In the News: MilliporeSigma Supporting Innovation in China with D1Med Collaboration

MilliporeSigma is collaborating with D1Med, a Shanghai-based biopharmaceutical start-up precision-medical company, to accelerate production of D1Med’s 3D cell culture technology applications used in the drug discovery process.

20201008
Oct 06, 2020
MilliporeSigma Inaugurates New, Upgraded Onsite Industrial Water Treatment Plant

MilliporeSigma today inaugurated a new $14.4 million industrial water treatment plant at its Jaffrey, New Hampshire, location.

20201006
Sep 15, 2020
MilliporeSigma Expands BioReliance® Viral Clearance Offering in Singapore, Saving Customers Time

MilliporeSigma today announced an expansion of its Singapore biosafety testing laboratory services.

20200915
Sep 09, 2020
MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion

MilliporeSigma today announced a $65 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin.

20200909
Sep 03, 2020
MilliporeSigma Supports Eijkman Institute to Expedite Covid-19 Vaccine Development Research

MilliporeSigma today announced the donation of research instruments and materials worth IDR 1.2 billion (€ 74,000) to support the efforts of Eijkman Institute for Molecular Biology, Indonesia, in its efforts to accelerate vaccine development research. The institute is developing a Covid-19 vaccine based on a local virus strain, in collaboration with several local research institutions.

20200903
Jul 30, 2020
MilliporeSigma’s DOZN™ Green Chemistry Tool Named Top Project of the Year by Environment + Energy Leader

MilliporeSigma today announced that it won a Top Project of the Year award from Environment + Energy Leader for its DOZN™ system, a quantitative tool that evaluates the relative greenness of chemicals and chemical processes against the 12 Principles of Green Chemistry.

20200730
Jul 15, 2020
MilliporeSigma Invests $20 Million in New Switzerland Laboratory

MilliporeSigma has announced plans to build a new, $20 million laboratory facility in Buchs, Switzerland to support its rapidly growing reference materials business.

20200715
Jul 10, 2020
MilliporeSigma Opens its Largest M Lab™ Collaboration Center in Shanghai

MilliporeSigma opened its M Lab™ Collaboration Center in Shanghai, the company’s largest of nine centers worldwide.

20200710
Jul 06, 2020
MilliporeSigma Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech Grant

MilliporeSigma today announced that VAR2 Pharmaceuticals has been selected as the European winner of its 2020 Advance Biotech Grant Program.

20200706
Jul 01, 2020
New Report Identifies Paths to Pandemic Resilience

A new report details potential paths to solutions to overcoming the global Covid-19 crisis and ways to prepare for or even prevent a future pandemic.

20200701
Jul 01, 2020
MilliporeSigma Advances Bioprocessing Capabilities with Raman Technology Sensor Acquisition

MilliporeSigma today enhanced its advanced bioprocess portfolio through the acquisition of RESOLUTION Spectra Systems.

20200701
Jun 10, 2020
MilliporeSigma and 10x Genomics Launch Powerful New Option for CRISPR Research

MilliporeSigma and 10x Genomics, Inc., a single cell and spatial genomics technologies company, today announced that they have developed a powerful new option for biological experiments.

20200610
May 27, 2020
MilliporeSigma and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19

MilliporeSigma and Baylor College of Medicine today announced an extension of their ongoing collaboration to advance a manufacturing platform to fight Covid-19.

20200527
May 11, 2020
MilliporeSigma Granted U.S. Patents for Foundational CRISPR-Cas9 Technology

MilliporeSigma today announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the United States.

20200511
Apr 30, 2020
MilliporeSigma Accelerates Readiness of Bioprocessing Facility of the Future

MilliporeSigma today unveiled the next component of its BioContinuum™ Platform, the Bio4C™ Software Suite, creating a first-of-its-kind ecosystem that combines process control, analytics and plant-level automation.

20200430
Apr 21, 2020
MilliporeSigma Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity

MilliporeSigma today announced a second Carlsbad, California-based facility for its BioReliance® viral and gene therapy service offering.

20200421
Apr 14, 2020
MilliporeSigma Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing

MilliporeSigma and The Jenner Institute today announced that The Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.

20200414
Apr 07, 2020
MilliporeSigma Awarded Second U.S. Patent for CRISPR Gene-Editing Technology

MilliporeSigma today announced that the United States Patent and Trademark Office has granted the company’s patent for CRISPR-chrom technology.

20200407
Mar 03, 2020
MilliporeSigma’s New LANEXO™ System to Improve Scientists’ Productivity in the Lab

MilliporeSigma today launched its LANEXO™ Lab Inventory, Safety and Compliance Management System, a new digital laboratory informatics solution designed to drastically reduce time in labs and improve data quality and traceability.

20200303
Feb 18, 2020
MilliporeSigma to Manufacture Elypta’s Liquid Biopsy Kits

MilliporeSigma today announced that it has been selected by Swedish molecular diagnostics firm Elypta as the contract manufacturer for Elypta’s clinical diagnostic liquid biopsy kits.

20200218
Feb 11, 2020
MilliporeSigma’s New BrightLab™ Cloud-hosted Software Brings IoT to R&D

MilliporeSigma today introduced its BrightLab™ cloud-based inventory management and instrument connectivity platform for research scientists.

20200211
Jan 10, 2020
MilliporeSigma and CSIR-IMTECH Open High-tech Skill Development Center

MilliporeSigma today announced the opening of new, non-profit center where Indian students and researchers can learn the latest genome-editing and single-molecule biomolecule biomarker detection technologies.

20200110
Dec 19, 2019
MilliporeSigma Licenses Foundational CRISPR Integration Technology to Promega

MilliporeSigma today announced that it has signed a license agreement providing Promega Corp.

20191219
Nov 26, 2019
Japan and Singapore Grant CRISPR Patents to MilliporeSigma

MilliporeSigma today announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed its patent application for the use of paired CRISPR nickases.

20191126
Nov 18, 2019
MilliporeSigma Wins R&D 100 Award for First-to-Market Biopharma Purification Innovation

MilliporeSigma today announced it has received a prestigious R&D 100 Award for its Eshmuno® CP-FT Resin, a first-to-market product used in biopharmaceutical manufacturing.

20191118
Nov 18, 2019
MilliporeSigma Expands in Gillingham, UK, Boosts Distribution Capabilities

MilliporeSigma today announced the completion of a £9 million expansion to its Gillingham distribution centre.

20191118
Nov 12, 2019
MilliporeSigma Licenses CRISPR Gene-Editing Technology to Evotec

MilliporeSigma today announced that it has signed a license agreement providing Evotec SE access to MilliporeSigma’s foundational CRISPR intellectual property.

20191112
Oct 10, 2019
MilliporeSigma Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing

MilliporeSigma today announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed.

20191010
Sep 19, 2019
MilliporeSigma Launches First Flagship Store on Alibaba’s 1688.com to Improve the Customer Experience

MilliporeSigma has launched its official flagship store (merckls.1688.com) on Alibaba’s 1688.com.

20190919
Aug 19, 2019
MilliporeSigma Granted 20 CRISPR Patents Total Worldwide

MilliporeSigma today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing MilliporeSigma’s patent application claims covering CRISPR gene-editing technology, bringing the number of patents to 20 worldwide.

20190819
Aug 06, 2019
MilliporeSigma Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab

MilliporeSigma has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and long-term archiving.

20190806
Jul 24, 2019
MilliporeSigma to Provide BioReliance® End-to-End Solutions to Phanes Therapeutics

MilliporeSigma today announced the signing of a non-binding Memorandum of Understanding (MoU) with Phanes Therapeutics, Inc. (Phanes) for a collaboration on the development and manufacture of biologics for the treatment of solid tumors.

20190724
Jul 18, 2019
MilliporeSigma and Broad Institute Announce CRISPR License Framework to Encourage Innovation

MilliporeSigma and the Broad Institute of MIT and Harvard today announced an agreement to offer non-exclusive licenses to CRISPR intellectual property (IP) under their respective control for use in commercial research and product development.

20190718
Jun 20, 2019
Massachusetts-based Business Sectors of Merck KGaA, Darmstadt, Germany Named ‘Best Places to Work’ by Boston Business Journal

MilliporeSigma, EMD Serono and EMD Performance Materials make prestigious Massachusetts top employer list for 2019

20190620 Water Purification,Small Molecule Pharmaceuticals,Reagents Chemicals and Labware,Life Science Research,Industrial Biomonitoring,IVD/OEM Materials and Reagents,Biopharmaceutical Manufacturing,Analytics and Sample Preparation
Jun 20, 2019
MilliporeSigma Introduces Mobile Laboratory to Promote Protein Research

MilliporeSigma today announced a national campus tour in China for the company’s first mobile protein research laboratory.

20190620
May 30, 2019
MilliporeSigma Awards Grants to Biotechs Focused on Traumatic Brain Injury, Vaccine Development and Chronic Pain

MilliporeSigma today announced the winners of its Advance Biotech Grant program in North America during its Biotech Start-up Summit at the Cambridge Innovation Center.

20190530
May 29, 2019
MilliporeSigma Announces Winners of School Science Competition

MilliporeSigma today announced that students from St Aloysius’ College in Carrigtwohill have won the company’s 2019 School Science Competition, now in its 15th year.

20190529
May 27, 2019
MilliporeSigma Expands Cell Culture Media Production Facility in Irvine

MilliporeSigma today announced the completion of a £2.7 million expansion to its Irvine biopharmaceutical production facility.

20190527
May 22, 2019
Experts Discuss Decentralized Manufacturing to Tackle Neglected Tropical Diseases and Promote Universal Health Coverage at World Health Assembly Event

Merck KGaA, Darmstadt, Germany, today hosted a panel discussion on the occasion of the 72nd World Health Assembly in Geneva, Switzerland.

20190522
May 20, 2019
MilliporeSigma Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing

MilliporeSigma today announced its participation in a collaboration with the Vaccine Formulation Institute and the European Vaccine Initiative.

20190520
May 07, 2019
MilliporeSigma Announces Winner of First Retrosynthetic Reaction Prediction Contest

MilliporeSigma today announced that MDL, a team from Beijing University, has won the company’s first Retrosynthetic Reaction Prediction Contest.

20190507
Apr 30, 2019
MilliporeSigma and India’s Food Safety and Standards Authority Partner on Skill Development in Food Safety

MilliporeSigma today announced the handover of a fully equipped microbiological testing laboratory to the Food Safety and Standards Authority of India (FSSAI).

20190430
Apr 24, 2019
MilliporeSigma Introduces New Greener Solvent, Cyrene™

MilliporeSigma today launched Cyrene™ — a sustainable dipolar aprotic solvent, produced in two steps from a renewable cellulose source.

20190424
Apr 04, 2019
MilliporeSigma Recognized with INTERPHEX Exhibitor Award for Best New Product

MilliporeSigma today announced that it has won an INTERPHEX Exhibitor Award for a new innovation in advancing next- generation bioprocessing. MilliporeSigma’s Pellicon® Capsule with Ultracel® Membrane has been recognized for Best New Product.

20190404 Biopharmaceutical Manufacturing
Apr 02, 2019
MilliporeSigma Elevates its BioContinuum™ Platform Strategy to Deliver ‘ContiGuous’ Bioprocessing

MilliporeSigma today unveiled its BioContinuum™ Buffer Delivery Platform, a new building block in the BioContinuum™ Platform for next-generation bioprocessing.

20190402 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Mar 20, 2019
MilliporeSigma Opens First M Lab™ Collaboration Center in Europe

MilliporeSigma today officially opened its new M Lab™ Collaboration Center in Molsheim, France.

20190320 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Mar 18, 2019
MilliporeSigma’s Milli-Q® Connect Combines Deep Water Purification Expertise with Cloud-based Digital Technology

MilliporeSigma today announced a new cloud-based, remote lab water service and monitoring capability available on all Milli-Q® CLX 7000 clinical water purification systems.

20190318 Water Purification
Mar 19, 2019
MilliporeSigma to Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China

MilliporeSigma today announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing.

20190319 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Mar 14, 2019
Zhejiang University Joins MilliporeSigma’s CRISPR Core Partnership Program

MilliporeSigma today announced a CRISPR core partnership with Zhejiang University in Hangzhou, China.

20190314
Mar 07, 2019
MilliporeSigma Brings Science Education to Students Across North America with Curiosity Cube® Mobile Science Lab

MilliporeSigma is igniting student interest in science with its third annual Curiosity Cube® mobile science lab tour.

20190307 Small Molecule Pharmaceuticals,Life Science Research,Biopharmaceutical Manufacturing
Mar 04, 2019
MilliporeSigma Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

MilliporeSigma today announced that the Canadian Patent Office has allowed MilliporeSigma’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells.

20190304 Small Molecule Pharmaceuticals,Life Science Research,Biopharmaceutical Manufacturing
Feb 19, 2019
MilliporeSigma Receives First U.S. Patent for Improved CRISPR Genome-Editing Method

MilliporeSigma today announced that the United States Patent and Trademark Office has issued a formal notice allowing MilliporeSigma’s patent application directed to its proxy-CRISPR technology.

20190219 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 04, 2019
MilliporeSigma Awards Grants to Biotechs Tackling Cancer and Cardiovascular Disease

MilliporeSigma today announced the winners of its Advance Biotech Grant program in Europe.

20190204 Life Science Research
Jan 15, 2019
MilliporeSigma Wins Life Science Industry Award® for Best Use of Social Media

MilliporeSigma today announced that it has been recognized by BioInformatics LLC with a 2018 Life Science Industry Award® for best use of social media.

20190115
Dec 19, 2018
MilliporeSigma Collaborates with Kuraray to Improve Drug Delivery

MilliporeSigma today announced it has extended and expanded its collaboration with Kuraray Europe to exclusively supply pharmaceutical polyvinyl alcohol (PVA) grades and improvements to benefit the pharmaceutical market.

20181219 Life Science Research
Dec 10, 2018
MilliporeSigma and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models

MilliporeSigma today announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based biotechnology company genOway.

20181210 Life Science Research
Nov 27, 2018
MilliporeSigma Wins Two R&D 100 Awards for Innovation in 2018

MilliporeSigma today announced that it has won two R&D 100 Awards.

20181127 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Nov 19, 2018
MilliporeSigma Announces Winners of 2018 Life Science Awards

MilliporeSigma recognized three graduate students who have demonstrated innovation in life science at an awards ceremony at the company’s global headquarters in Darmstadt, Germany recently.

20181119 Life Science Research
Nov 05, 2018
MilliporeSigma Launches BioContinuum™ Platform for Next-Generation Process Improvements

MilliporeSigma today launched its new BioContinuum™ Platform to advance biotherapeutic drug manufacturing through improved efficiency, simplified plant operations and greater quality and consistency.

20181105 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Oct 18, 2018
MilliporeSigma Announces Agreement to Sell Amnis® Flow Cytometry and Guava® Technologies Businesses to Luminex Corporation

MilliporeSigma today announced the signing of a definitive agreement to sell its Flow Cytometry unit to Luminex Corporation for $75 million.

20181018
Oct 12, 2018
MilliporeSigma Recognized with CPhI Awards for Innovative Products

MilliporeSigma today announced that it has won two CPhI Pharma Awards for innovative products for the pharmaceutical industry.

20181012 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Oct 04, 2018
MilliporeSigma Opens M Lab™ Collaboration Center in São Paulo, Brazil

MilliporeSigma today officially opened a state-of-the-art M Lab™ Collaboration Center in Brazil, serving the Latin America region.

20181004 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Oct 02, 2018
MilliporeSigma Announces $3,000 Grand Prize Winner of Alfred R. Bader Award for Student Innovation

MilliporeSigma recognized four graduate students for their research and innovations in synthetic organic chemistry as part of the Alfred R. Bader Student Chemistry Symposium in Darmstadt, Germany, on September 27.

20181002
Sep 18, 2018
MilliporeSigma Makes Major Investment in New Singapore Laboratory

MilliporeSigma today announced the opening of a new 3,800-square-meter laboratory in Singapore.

20180918
Sep 12, 2018
MilliporeSigma to Open China’s First Mobius® Single-use Manufacturing Facility in Wuxi

MilliporeSigma today announced the establishment of its first Mobius® Single-use Manufacturing Facility in China.

20180912
Sep 04, 2018
MilliporeSigma Launches Next-Generation Process Technologies for Intensified Drug Production

MilliporeSigma today launched three new products to help biomanufacturers navigate the evolving biopharma landscape with increased speed, greater flexibility and enhanced quality.

20180904 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Aug 15, 2018
MilliporeSigma Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology

MilliporeSigma today announced that the Australian Patent Office has allowed the company’s patent application for the use of paired CRISPR nickases.

20180815 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jul 26, 2018
MilliporeSigma and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery Technology

MilliporeSigma and InnoCore Pharmaceuticals; Groningen, Netherlands, have entered into a global cooperation agreement to provide InnoCore’s proprietary SynBiosys® biodegradable polymer platform.

20180726 Life Science Research
Jul 02, 2018
MilliporeSigma to Expand Operations in Gillingham, UK

MilliporeSigma today announced plans to expand its Gillingham, UK distribution centre.

20180702
Jun 20, 2018
Tongji University Joins MilliporeSigma’s CRISPR Core Partnership Program

MilliporeSigma today announced a new CRISPR core partnership with Tongji University in Shanghai.

20180620 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jun 19, 2018
MilliporeSigma Signs Exclusive Agreement with HistoCyte Laboratories to Distribute Pathology Technology

MilliporeSigma today announced that it has entered into an agreement with HistoCyte Laboratories Ltd, Tyne, U.K. to be the exclusive multinational distributor of the company’s portfolio of cell line reference products for immunohistochemistry and in situ hybridization.

20180619 Life Science Research
Jun 12, 2018
Merck KGaA, Darmstadt, Germany Drives Thought Leadership in Ethical Gene Editing

Merck KGaA, Darmstadt, Germany, today announced that The American Journal of Bioethics has accepted a novel publication on ethical issues in genome editing to be printed in its July issue.

20180612 Life Science Research,Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jun 06, 2018
Merck KGaA, Darmstadt, Germany Completes Third and Final Registration Phase under the European Chemicals Regulation REACH

Merck KGaA, Darmstadt, Germany, today announced that it has successfully submitted a total of more than 1,000 registration dossiers under the European chemicals regulation REACH by the end of the third and final registration deadline of May 31, 2018.

20180606
Jun 05, 2018
MilliporeSigma Brings Biotechs Closer to Drug Therapy Production and Commercialization

MilliporeSigma today officially opened North America’s first BioReliance® End-to-End Biodevelopment Center providing cell line development services, upstream and downstream process development and non-GMP clinical production for drug manufacturers.

20180605 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
May 29, 2018
MilliporeSigma Announces Collaboration with Solvias for New Pyrogen Detection Kit

MilliporeSigma today announced a collaboration with Solvias, a Swiss contract research and service provider, to offer the PyroMAT™ System, a new MAT kit for pyrogen detection.

20180529 Life Science Research
May 16, 2018
MilliporeSigma to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children

MilliporeSigma today announced a collaboration with Washington University in St. Louis that could lead to the optimizing of nutritional supplements to restore a healthy gut microbial community (microbiome).

20180516 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Apr 27, 2018
MilliporeSigma Advances Cell Analysis with New Benchtop Flow Cytometer with Camera Detection

MilliporeSigma today launched its new CellStream™ benchtop flow cytometry system, a compact, customizable flow cytometer that uses a camera for detection.

20180427 Life Science Research
Apr 23, 2018
MilliporeSigma Receives Patent for CRISPR Technology in China

MilliporeSigma today announced that the Chinese Patent Office has issued a notice granting MilliporeSigma’s patent application for the company’s CRISPR technology used in a genomic-integration method for eukaryotic cells.

20180423 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Apr 18, 2018
MilliporeSigma Wins INTERPHEX Exhibitor Award for Best Technological Innovation

MilliporeSigma today announced that its Millistak+® HC Pro portfolio has won an INTERPHEX Exhibitor Award for Best Technological Innovation.

20180418 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Apr 17, 2018
MilliporeSigma Introduces New Single-use Technologies to Advance Flexible Manufacturing

MilliporeSigma today introduced three new products to support flexible manufacturing of biologics.

20180417
Apr 12, 2018
MilliporeSigma Helps Accelerate Global Access to Affordable Vaccines

MilliporeSigma today announced a partnership with Oxford University’s Jenner Institute to develop more robust and scalable vaccine manufacturing processes.

20180412 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Mar 28, 2018
MilliporeSigma Named Best Bioprocessing Supplier in Asia

MilliporeSigma was named the overall “Best Bioprocessing Supplier” and won the sub-category of “Best Bioprocessing Supplier Award for Single-use Systems” at the Asia-Pacific Bioprocessing Excellence Awards 2018 ceremony.

20180328 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Mar 05, 2018
MilliporeSigma and Schneider Electric Sign MoU to Advance China’s Biopharmaceutical Industry

MilliporeSigma and Schneider Electric, a global specialist in energy management and automation, today announced the signing of a Memorandum of Understanding (MoU) that aims to automate the mAb process for China’s biopharmaceutical industry.

20180305 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 28, 2018
MilliporeSigma Furthers Scientists’ Research Through Expanded Seeding Labs Partnership

MilliporeSigma today announced an expansion of its partnership with Seeding Labs to accelerate teaching and research for thousands of scientists in the developing world.

20180228 Life Science Research
Feb 27, 2018
MilliporeSigma Announces €300,000 in Grants to Accelerate Therapeutic Research in Life Science

MilliporeSigma today announced the recipients of its Emerging Biotech Grant Program in China.

20180227 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 26, 2018
MilliporeSigma Announces 2018 North American Curiosity Cube™ Mobile Science Lab Tour

MilliporeSigma today announced plans for its second annual Curiosity Cube™ mobile science lab tour, which will kick off in February and visit more than 100 communities in the U.S. and Canada.

20180226 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 22, 2018
MilliporeSigma Announces Investment in India with New Life Science Manufacturing & Distribution Centre

MilliporeSigma today announced that it will invest €16.6 million in its new manufacturing and distribution centre for the Life Science business, located near Mumbai, India.

20180222 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 22, 2018
MilliporeSigma Signs Agreement with Incheon Free Economic Zone to Build Cell Culture Facility in South Korea

MilliporeSigma today announced it has signed an agreement with Incheon Free Economic Zone (IFEZ) to build an integrated cell culture facility in Songdo, Incheon.

20180222 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 22, 2018
MilliporeSigma Accelerates Mobius® Single-Use Manufacturing in Wuxi

MilliporeSigma today announced an additional investment to accelerate Mobius® single-use manufacturing in Wuxi, China.

20180222 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 22, 2018
MilliporeSigma Strengthens Corporate Responsibility Efforts with Nine New Signature Partnerships

MilliporeSigma today announced nine new or expanded partnerships with leading nonprofit organizations across the world.

20180222
Feb 21, 2018
MilliporeSigma Invests Additional $50 Million to Enhance Manufacturing and Distribution in Asia

MilliporeSigma today announced an additional investment of $50 million to build a robust manufacturing and distribution platform in Asia over a span of two years.

20180221
Feb 20, 2018
MilliporeSigma Receives Two More Patents for CRISPR Technology

MilliporeSigma today announced that the Korean Intellectual Property Office and the Israel Patent Office have each issued notices granting MilliporeSigma’s patent applications for the company’s CRISPR technology.

20180220 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 13, 2018
MilliporeSigma Launches Viresolve® Barrier Capsule Filters to Protect Against Bioreactor Contamination

MilliporeSigma today introduced Viresolve® Barrier capsule filters to reduce the risk of bioreactor contamination.

20180213 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 01, 2018
Merck KGaA, Darmstadt, Germany Certified as one of the Top Employers North America 2018

For the second year in a row, the North American businesses of Merck KGaA, Darmstadt, Germany, a leading science and technology company, have been certified for the company’s outstanding employee offerings by the independent Top Employers Institute.

20180201
Dec 20, 2017
MilliporeSigma Collaborates with iCON™ to Offer BioReliance® End-to-End Turnkey Modular MAb Manufacturing Platform

MilliporeSigma today announced a collaboration with IPS-Integrated Project Services, LLC and G-CON Manufacturing, Inc. to provide the most advanced 2,000L monoclonal antibody (MAb) facility and single-use process technology platform.

20171220 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Dec 20, 2017
MilliporeSigma Signs Commercial Supply Agreement with bluebird bio for Viral Vector Manufacturing

MilliporeSigma today announced that it has signed a commercial supply agreement to manufacture viral vectors for bluebird bio, Inc., of Cambridge, Massachusetts, for its use in potentially transformative gene therapies.

20171220
Dec 19, 2017
Singapore’s IP Office to Grant MilliporeSigma's Patent Application for CRISPR Technology

MilliporeSigma today announced that the Intellectual Property Office of Singapore has issued a “Notice of Eligibility for Grant” for MilliporeSigma’s patent application covering the company’s CRISPR technology.

20171219 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Dec 11, 2017
MilliporeSigma Signs Distribution Agreement with Avanti® Polar Lipids

MilliporeSigma today announced that it has entered into an agreement with Avanti® Polar Lipids to be the exclusive multinational distributor of the Alabama-based company’s research lipids portfolio outside of the United States.

20171211 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Nov 17, 2017
Merck KGaA, Darmstadt, Germany's Massachusetts-based Business Sectors Named 'Top Place to Work' by The Boston Globe

Merck KGaA, Darmstadt, Germany today announced that its Massachusetts-based business sectors, EMD Serono and MilliporeSigma, have been named to The Boston Globe's annual "Top Places to Work" list for the second year in a row.

20171117
Nov 13, 2017
MilliporeSigma Introduces Stericup® Quick Release System for Improved Cell Culture Filtration

MilliporeSigma today launched the new Stericup® Quick Release 500 mL vacuum filtration system.

20171113 Life Science Research
Nov 01, 2017
MilliporeSigma and Samsung BioLogics to Extend Strategic Alliance

MilliporeSigma today announced the signing of a Memorandum of Understanding (MoU) with Samsung BioLogics for a strategic alliance on biopharmaceutical manufacturing and biologics process development.

20171101 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Oct 24, 2017
Canadian Patent Office to Grant MilliporeSigma's Patent Application for CRISPR Technology

MilliporeSigma today announced that the Canadian Patent Office has issued a “Notice of Allowance” for MilliporeSigma’s patent application covering the company’s CRISPR technology.

20171024 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Oct 23, 2017
MilliporeSigma Announces $10,000 Grand Prize Winners of 2017 Life Science Awards

MilliporeSigma has recognized a group of outstanding postgraduate students for their research and innovations in life science at an awards ceremony.

20171023
Oct 19, 2017
MilliporeSigma Brings Customers Closer to Gene Therapy Product Commercialization

MilliporeSigma today announced that its Carlsbad, California-based manufacturing facility for the production of BioReliance® viral and gene therapy products has completed both a U.S. Food & Drug Administration (FDA) Pre-License inspection and a European Medicines Agency (EMA) Marketing Authorization Application inspection.

20171019 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Oct 11, 2017
MilliporeSigma Opens New Life Science Center in Massachusetts for Scientific Collaboration

MilliporeSigma will welcome world-renowned academic researchers, technology experts and industry entrepreneurs to discuss advances and opportunities in some of the most exciting areas of life science on Wednesday, October 11, 2017, 10 a.m. at the company’s new Life Science Center in Burlington.

20171011
Oct 10, 2017
MilliporeSigma Presents ‘Future Forum’ at Boston’s HUBweek 2017

MilliporeSigma today announced that it will host a panel discussion, “The Personalized Cell Therapy Challenge: A Race Against Time,” featuring leading cell and gene therapy experts from academia, hospitals and industry, on Thursday, October 12, 3:30 p.m. at the HUBweek Green Dome at City Hall Plaza in Boston.

20171010
Oct 10, 2017
MilliporeSigma Hosts Leading Scientists at Life Science Symposium in Greater Boston

MilliporeSigma will welcome world-renowned academic researchers, technology experts and industry entrepreneurs to discuss advances and opportunities in some of the most exciting areas of life science on Wednesday, October 11, 2017, 10 a.m. at the company’s new Life Science Center in Burlington.

20171010 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Sep 27, 2017
MilliporeSigma Provides Update on EU’s Horizon 2020 Program to Improve Biopharmaceutical Downstream Processing

MilliporeSigma today announced an update on its participation in Horizon 2020, the EU Framework Program for Research and Innovation, to improve biopharmaceutical downstream processing.

20170927 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Sep 26, 2017
New, First-of-its Kind Filters by MilliporeSigma Provide Twice the Filtration Capacity using Fully Synthetic Materials

MilliporeSigma today announced Millistak+® HC Pro, the first portfolio of high- capacity, fully synthetic depth filters for non-treated Chinese Hamster Ovary (CHO) harvest clarification and downstream filtration applications.

20170926 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Sep 22, 2017
MilliporeSigma Opens China’s First BioReliance® End-to-End Biodevelopment Center in Shanghai

MilliporeSigma today announced the opening of its first BioReliance® End-to-End Biodevelopment Center in the Asia Pacific (APAC) region.

20170922 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Sep 20, 2017
MilliporeSigma Introduces Eshmuno® P Anti-A and Anti-B Chromatography Resins for Enhancement of Plasma-Derived Immunoglobulin

MilliporeSigma today launched Eshmuno® P anti-A and Eshmuno® P anti-B affinity chromatography resins specifically designed to remove anti-A and anti-B isoagglutinin antibodies during the manufacturing of plasma-derived immunoglobulin (Ig) therapies.

20170920 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Sep 13, 2017
MilliporeSigma Expands Celonic’s Upstream Capabilities with Mobius® Single-use Bioreactors

MilliporeSigma today announced that Celonic AG, a Swiss contract development and manufacturing organization (CDMO), is upgrading its manufacturing facility with five of MilliporeSigma’s Mobius® single-use bioreactors.

20170913 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Sep 11, 2017
MilliporeSigma Announces $5,000 Grand Prize Winner of Alfred R. Bader Award for Student Innovation

MilliporeSigma recognized four student chemists for their research and innovations in synthetic organic chemistry as part of the Alfred R. Bader Student Chemistry Symposium.

20170911
Aug 28, 2017
MilliporeSigma to Acquire Natrix Separations to Advance Next-Generation Processing Capabilities

MilliporeSigma today announced that it has entered into an agreement to acquire Natrix Separations, an Ontario, Canada-based provider of hydrogel membrane products for single-use chromatography.

20170828 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Aug 30, 2017
MilliporeSigma Opens its First Customer Food Safety Studio

MilliporeSigma has opened its first global Food Safety Studio in Bellevue, Washington for manufacturers of all types of food to collaborate with MilliporeSigma scientists.

20170830 Analytics and Sample Preparation
Aug 29, 2017
MilliporeSigma Collaborates with Angiex to Speed Clinical Readiness of New Cancer Therapy

MilliporeSigma today announced a new collaboration with Angiex, Inc., Cambridge, Massachusetts, to support the biotechnology start-up’s ability to speed its lead oncology antibody drug candidate to clinical use.

20170829 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Aug 08, 2017
MilliporeSigma and Baylor College of Medicine Advance Vaccine Development and Manufacturing for Neglected Diseases

MilliporeSigma today announced that it has formed a strategic alliance with Baylor College of Medicine...

20170808 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Aug 03, 2017
European Patent Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology

MilliporeSigma today announced that the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for MilliporeSigma’s patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells.

20170803 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jun 27, 2017
MilliporeSigma Wins False Advertising Lawsuit Against Distributor of RephiLe Bioscience Lab Water Products

MilliporeSigma today announced that it has prevailed against Analis S.A. in a lawsuit ordering the Belgium-based laboratory equipment distributor to cease advertising that compares RephiLe Bioscience Ltd.’s lab water products with the lab water products of MilliporeSigma.

20170627 Water Purification
Jun 26, 2017
MilliporeSigma adds Chemical Products to Reaxys’ Chemistry Database

MilliporeSigma today announced a collaboration with Elsevier, the information analytics company specializing in science and health, to add its products into Reaxys, Elsevier’s chemistry database.

20170626 Reagents Chemicals and Labware
Jun 15, 2017
MilliporeSigma Expands Distribution Agreement with Public Health England

MilliporeSigma today announced an expansion of its distribution alliance with Public Health England (PHE) to include the European Bank for induced pluripotent Stem Cells (EBiSC).

20170615
Jun 14, 2017
MilliporeSigma Awarded its First CRISPR Patent by Australian Patent Office

MilliporeSigma today announced that the Australian Patent Office has granted the company patent rights relating to the use of CRISPR in a genomic integration method for eukaryotic cells.

20170614 Life Science Research
May 16, 2017
MilliporeSigma’s CHOZN® Expression System Selected for Bi-specific Antibody Development by SystImmune

MilliporeSigma today announced that its CHOZN® expression system will be used by SystImmune, a Seattle-based biotechnology company, for commercial development of a bi-specific antibody therapeutic.

20170516 Life Science Research
May 17, 2017
MilliporeSigma Develops Alternative CRISPR Genome Editing Method

MilliporeSigma today has developed a new genome editing tool that makes CRISPR more efficient, flexible and specific.

20170517 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
May 15, 2017
MilliporeSigma Launches Industry’s First Off-the-Shelf Cell Culture Media for Perfusion Processes

MilliporeSigma today took a significant step toward increasing manufacturing flexibility and enabling higher productivity with the launch of the EX-CELL® Advanced™ HD Perfusion Medium.

20170515 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
May 12, 2017
MilliporeSigma Opens New M Lab™ Collaboration Center in Bangalore

MilliporeSigma today announced the expansion of its M Lab™ Collaboration Center in Bangalore, India.

20170512
May 12, 2017
MilliporeSigma and Stelis Biopharma Open First Joint Bioprocess Scale-up Lab in India

MilliporeSigma today announced the opening of a new joint Process Scale-Up Lab in Bengaluru, India to provide end-to-end solutions from process development to scale-up manufacturing for pre-clinical, clinical and commercial supply.

20170512 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
May 09, 2017
MilliporeSigma Acquires Grzybowski Scientific Inventions to Expand Chemical Synthesis Offering

MilliporeSigma today announced the acquisition of Grzybowski Scientific Inventions (GSI), a company that developed the revolutionary computer-aided retro-synthesis tool, Chematica.

20170509
May 01, 2017
MilliporeSigma’s Mobius® 2,000-liter Single-use Bioreactors to Expand Avid Bioservices’ Manufacturing Capabilities

MilliporeSigma and Avid Bioservices, Inc., today announced that Avid will upgrade its Myford clinical and commercial manufacturing facility with multiple Mobius® 2000-liter single-use bioreactors from MilliporeSigma.

20170501 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Apr 25, 2017
MilliporeSigma Collaborates with LabCentral to Foster Biotech Startups

MilliporeSigma announced today that the company will sponsor the Startup Program at LabCentral, a biotechnology incubator, in Cambridge, Massachusetts.

20170425
Apr 20, 2017
MilliporeSigma Provides Upgraded Manufacturing Capabilities to BioInvent with Single-use Mobius® Bioreactors

MilliporeSigma has announced that BioInvent International AB, a Swedish company which develops novel immuno-regulatory antibodies to treat cancer, is upgrading and expanding its drug manufacturing facility with a full line of MilliporeSigma’s Mobius® single-use bioreactors.

20170420 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Apr 05, 2017
MilliporeSigma Announces First Stops in National Curiosity Cube™ Tour

MilliporeSigma has announced nine stops for the first half of its national, year-long Curiosity Cube™ tour.

20170405
Apr 03, 2017
MilliporeSigma Introduces Next-Generation High-Sensitivity Protein Detection Platform

MilliporeSigma launched its newest high-sensitivity detection platform, SMCxPRO™ technology, at the American Association for Cancer Research Annual Meeting in Washington, D.C.

20170403 Life Science Research
Mar 21, 2017
MilliporeSigma Introduces Mobius® MyWay Portfolio for Customized Single-use Assemblies

MilliporeSigma today launched the Mobius® MyWay portfolio, a program that allows more flexibility, better supply predictability and shorter lead times for more efficient and safer drug manufacture.

20170321 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Mar 06, 2017
MilliporeSigma Advances Lab Water Purification Technology with Milli-Q® IQ 7000 System

MilliporeSigma today announced the global launch of the Milli-Q® IQ 7000 system, the seventh-generation Milli-Q® water purification innovation.

20170306 Water Purification
Feb 15, 2017
MilliporeSigma to Supply Single-use Systems to WuXi Biologics for Non-GMP Pilot Plant in Shanghai

MilliporeSigma was selected by contract development and manufacturing organization WuXi Biologics to provide MilliporeSigma’s Mobius® single-use systems and technologies to fully equip a non-GMP pilot plant in Shanghai, China.

20170215 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 08, 2017
North American Businesses of Merck KGaA, Darmstadt, Germany Certified as 2017 Top Employer

Merck KGaA, Darmstadt, Germany has announced that its North American businesses have been certified by the Top Employers Institute for exceptional employee offerings.

20170208
Feb 03, 2017
MilliporeSigma Wins Scotland’s Life Science Award for Excellence in Community Engagement

MilliporeSigma has received the 2017 Scotland’s Life Science Award for outstanding achievements in community engagement.

20170203
Jan 23, 2017
MilliporeSigma Announces Emerging Biotech Grant Program Winners in Europe

MilliporeSigma has announced the winners of its Emerging Biotech Grant Program in Europe.

20170123 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jan 12, 2017
MilliporeSigma Kicks Off Year-Long ‘Curiosity Cube™’ Tour

Recognizing that tomorrow’s discoveries depend on the next generation of scientists, MilliporeSigma has kicked off a year-long “Curiosity Cube™” tour.

20170112
Jan 10, 2017
MilliporeSigma Expands End-to-End Biodevelopment Centers in North America, China and Europe

MilliporeSigma today announced the expansion of its end-to-end biodevelopment centers to meet increasing customer demand for its turnkey portfolio of bioprocessing products, manufacturing capabilities and industry leading technological expertise.

20170110 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jan 04, 2017
MilliporeSigma Acquires BioControl to Strengthen Position in Food Safety Testing

MilliporeSigma today announced it has acquired BioControl Systems Inc., a global leader in food safety testing.

20170104 Biopharmaceutical Manufacturing
Jan 18, 2017
MilliporeSigma Launches First Commercial Service to Predict Multiple Sources of DNA Damage

MilliporeSigma has introduced CAN MultiFlow™ screening services to more accurately predict genotoxic and mode of action* properties of substances, ingredients and drug compounds.

20170118
Jan 13, 2017
MilliporeSigma Introduces New Calibration Kit for In Vitro Diagnostic Use

MilliporeSigma today announced the introduction of its new testosterone calibrator kit for in vitro diagnostic (IVD) use.

20170113
Jan 17, 2017
MilliporeSigma Opens Production Facility Exclusively for Meglumine in Spain

MilliporeSigma today announced the opening of a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media.

20170117 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Dec 19, 2016
MilliporeSigma Announces Winner of Life Science Award in Bioseparations

MilliporeSigma today announced that Ying Li, from The Pennsylvania State University, has won the company’s Life Science Award in Bioseparations.

20161219
Dec 16, 2016
MilliporeSigma Wins Life Science Industry Award® for Most Memorable Advertising

MilliporeSigma today announced that it has been recognized by BioInformatics LLC with a 2016 Life Science Industry Award® for most memorable advertising.

20161216
Dec 05, 2016
MilliporeSigma to Provide Provantage® End-to-End Services to Acticor Biotech SAS

MilliporeSigma today announced that it will provide its Provantage® End-to-End services to Acticor Biotech SAS for accelerated development and manufacturing of Acticor’s antibody fragment used for the primary treatment of ischemic stroke.

20161205 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Dec 02, 2016
MilliporeSigma Launches Parteck® MXP Excipient for Increased Solubility

MilliporeSigma today introduced Parteck® MXP, a polyvinyl alcohol-based excipient that enhances solubility of a wide range of active pharmaceutical ingredients (APIs) with poor bioavailability.

20161202 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Dec 02, 2016
MilliporeSigma Introduces MILLIPLEX® High Sensitivity Panel for Faster, More Economical Cytokine Assays

MilliporeSigma today launched the MILLIPLEX® MAP Human High Sensitivity cytokine panel for faster and more cost-effective human cytokine assays.

20161202 Life Science Research
Dec 01, 2016
MilliporeSigma Expands Distribution Agreement with Roche in Canada

MilliporeSigma today announced an expansion of its distribution alliance with Roche to include the polymerase chain reaction (PCR) and quantitative real-time PCR (qPCR) enzyme products of Kapa Biosystems, a company acquired by Roche in 2015.

20161201
Nov 30, 2016
MilliporeSigma Collaborates with Evotec for Faster Target Identification Solution

MilliporeSigma today announced that it has entered into a set of agreements with Evotec AG, whereby Evotec AG will provide screening services for MilliporeSigma’s collection of genetic reagents such as CRISPR and shRNA libraries.

20161130
Nov 18, 2016
MilliporeSigma named ‘Top Place to Work’ by The Boston Globe

MilliporeSigma today announced that it has been named to The Boston Globe’s annual “Top Places to Work” list.

20161118
Nov 15, 2016
MilliporeSigma Wins US Search Award for ‘Best In-House’ Team

MilliporeSigma today announced that its digital acquisition marketing team won the 2016 US Search award for “Best In-House” team.

20161115
Nov 14, 2016
MilliporeSigma Launches Next-Generation Technology for Advanced Live Cell Imaging

MilliporeSigma has launched the CellASIC® ONIX2 Microfluidic System for advanced live cell imaging.

20161114 Life Science Research
Nov 11, 2016
MilliporeSigma Wins R&D 100 Award for Top Invention

MilliporeSigma has received a prestigious R&D 100 Award for its Sanger Arrayed Lentiviral CRISPR Libraries—the first of its kind CRISPR libraries.

20161111
Oct 13, 2016
MilliporeSigma Introduces First Certified Spiking Solution® of Heavy Labeled Thyroglobulin Protein

MilliporeSigma today introduced the first Certified Spiking Solution® of intact, heavy labeled Thyroglobulin (Tg) in SigMatrix®, a synthetic surrogate serum.

20161013 Reagents Chemicals and Labware,IVD/OEM Materials and Reagents,Analytics and Sample Preparation
Oct 06, 2016
MilliporeSigma Unveils New State-of-the-Art M Lab™ Collaboration Center in Korea

MilliporeSigma today announced the opening of an M Lab™ Collaboration Center in the Songdo district of Incheon, Korea, one of the fastest growing biotech hubs in Asia.

20161006 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Oct 05, 2016
MilliporeSigma’s Udit Batra Receives CPhI’s ‘CEO of the Year’ Award

MilliporeSigma today announced that CEO Udit Batra was named “CEO of the Year” for 2016 by CPhI Pharma for his commitment to furthering life science innovation globally.

20161005 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Sep 26, 2016
MilliporeSigma Launches Viresolve® Pro Shield H for More Robust, Economical Parvovirus Removal

MilliporeSigma today launched the Viresolve® Pro Shield H for removal of parvoviruses from therapeutic protein feed streams.

20160926 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Sep 19, 2016
MilliporeSigma’s New Steritest™ Symbio Pump Accessories Enable Faster, Sterility Testing in Any Setting

MilliporeSigma has introduced a set of Steritest™ Symbio Pump systems accessories that accelerate and streamline sterility testing workflows.

20160919 Industrial Biomonitoring
Sep 14, 2016
Merck KGaA, Darmstadt, Germany, Joins DiViNe Consortium to Address Low Yields, High Costs of Vaccine Purification Processes

Merck KGaA, Darmstadt, Germany, has joined the DiViNe project, a European consortium of six companies to address the biggest challenges facing the development, manufacture and delivery of vaccines.

20160914
Sep 13, 2016
MilliporeSigma Lab Earns ISO Accreditation for Quality Control of Culture Media

MilliporeSigma today announced that its microbiology quality control laboratory in Eppelheim, Germany, is now accredited for the quality control of the ReadyPlate™ and ReadyTube™ culture media tested there.

20160913 Industrial Biomonitoring
Sep 08, 2016
MilliporeSigma Launches New Gene Editing Technology to Engineer Virus Resistant CHO Cell Lines

MilliporeSigma today launched a first-of-its-kind gene editing technology to modify CHO cell lines to be resistant to minute virus of mice (MVM), a common contamination threat that remains despite the shift to chemically-defined, animal component-free manufacturing processes.

20160908 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Aug 03, 2016
MilliporeSigma Expands Portfolio of Certified Reference Materials for Applied Diagnostics and Testing

MilliporeSigma today announced the expansion of its portfolio of Cerilliant® certified reference materials (CRMs) with nine new Certified Spiking Solutions® used in laboratories around the world.

20160803 Reagents Chemicals and Labware,Analytics and Sample Preparation
Aug 01, 2016
MilliporeSigma to Provide Provantage® End-to-End Development and Manufacturing Services to Y-mAbs for Lead Antibody Compound

MilliporeSigma will provide its Provantage® End-to-End development and manufacturing services to Y-mAbs Therapeutics, Inc. in support of Y-mAbs’ monoclonal antibody in late stage clinical development.

20160801 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jul 19, 2016
MilliporeSigma Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts

MilliporeSigma today announced plans to build a new campus in Burlington, Massachusetts that will serve as a major hub for the North American life science business of Merck KGaA, Darmstadt, Germany.

20160719
Jul 18, 2016
MilliporeSigma Relaunches Customer Collaboration Centers with New Concept and M Lab™ Name

MilliporeSigma today is relaunching its global network of customer collaboration centers, providing customers a shared, exploratory environment with scientists and engineers working to solve their toughest biomanufacturing challenges and helping accelerate development of new therapies.

20160718 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jul 13, 2016
MilliporeSigma Advances Water Purification Systems with New High-Throughput Line

MilliporeSigma today introduced the Elix® High-Throughput water purification system, providing laboratories with a reliable water purification solution for daily water volumes of up to 9000 liters.

20160713 Water Purification
Jul 12, 2016
MilliporeSigma Expands Excipients Portfolio, Adding Polymers for Sustained Release Injectables

MilliporeSigma has entered into an agreement with PCAS S.A. (Longjumeau, France) to expand MilliporeSigma’s excipients portfolio.

20160712 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jun 28, 2016
MilliporeSigma Expands Industry-Leading Emprove® Program to Include Filtration and Single-Use Products

MilliporeSigma today has expanded its industry-leading Emprove® risk assessment program to include a selection of products for filtration and single-use processing.

20160628 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jun 28, 2016
MilliporeSigma to Develop Next-Generation Purification Processes with International Vaccine Institute

MilliporeSigma has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.

20160628 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jun 07, 2016
MilliporeSigma Announces Survey Results Exploring Biopharma Industry’s Evolving Risk Model

MilliporeSigma today announced survey results of 250 global biopharmaceutical executives on how their companies will manage new risks associated with the changing biopharma landscape.

20160607 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
May 11, 2016
MilliporeSigma Expands Popular Line of Guava® Flow Cytometers

MilliporeSigma today announced it has expanded its popular line of Guava® flow cytometers to include a high-power modulated green laser.

20160511 Life Science Research
May 10, 2016
MilliporeSigma Showcases New Innovations at Analytica 2016

MilliporeSigma will exhibit a new range of products and solutions at Analytica 2016, the international trade fair for laboratory technology, analysis and biotechnology, held May 10-13 in Munich, Germany.

20160510 Water Purification,Reagents Chemicals and Labware,Life Science Research,Industrial Biomonitoring,IVD/OEM Materials and Reagents,Analytics and Sample Preparation
May 09, 2016
MilliporeSigma Launches First Commercially Available Equine-Specific Multiplex Assay for Protein Biomarkers

MilliporeSigma today announced the launch of the first commercially-available equine-specific multiplex assay for protein biomarkers.

20160509 Life Science Research
May 04, 2016
MilliporeSigma Builds on Leading Viral and Gene Therapy Service Offering with Capacity Expansion

MilliporeSigma today announced an expansion of its Carlsbad, California facility to meet growing demand for viral and gene therapy products.

20160504 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
May 02, 2016
MilliporeSigma Expands Production Know-how to Deliver Full End-To-End Solution for Biopharma Industry

MilliporeSigma today announced the expansion of its state-of-the art single use current good manufacturing process (cGMP) facility with the addition of the Mobius® 2000L single-use bioreactor.

20160502 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Apr 27, 2016
New MilliporeSigma Products Bring Ease of Use to Single-Use

MilliporeSigma is launching three Mobius® products that deliver improved efficiency and ease-of-use for biopharmaceutical manufacturing workflows.

20160427 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Apr 26, 2016
MilliporeSigma Introduces First Multi-use Disposable Sterile Connectors for Biopharma at INTERPHEX 2016

MilliporeSigma today announced the launch of its first-in-class Lynx® CDR connectors to improve fluid management in the biopharma industry.

20160426 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Apr 19, 2016
MilliporeSigma Earns Accreditation for Quality Control of Culture Media

MilliporeSigma has received accreditation for the quality control of dehydrated culture media tested at its Microbiology Quality Control Laboratory in Darmstadt.

20160419 Industrial Biomonitoring
Apr 14, 2016
Merck KGaA, Darmstadt, Germany Supports Next Generation of Scientists at USA Science & Engineering Festival

Merck KGaA, Darmstadt, Germany today announced that it is participating in the 4th USA Science & Engineering Festival (USASEF), April 16-17, 2016 in Washington D.C.

20160414
Mar 29, 2016
MilliporeSigma’s CRISPR Epigenetic Activator Named to The Scientist’s Top 10 Innovation List

MilliporeSigma today announced that The Scientist magazine has named the company’s CRISPR Epigenetic Activator one of its Top 10 Innovations of 2015.

20160329 Life Science Research
Mar 21, 2016
MilliporeSigma Introduces IsoBag™ for Faster and Easier Transfer of Contact and Settle Plates

MilliporeSigma today introduced the IsoBag™ for faster, easier and more convenient transfer of contact and settle plates to production isolators.

20160321 Industrial Biomonitoring
Mar 07, 2016
Life Science Leader MilliporeSigma Launches New Innovations at Pittcon 2016

MilliporeSigma is launching a range of new products for separation and analysis at the Pittcon Conference and Expo 2016 in Atlanta, Georgia, March 6 – 10, the world’s largest conference for laboratory science.

20160307 Water Purification,Reagents Chemicals and Labware,Industrial Biomonitoring,Analytics and Sample Preparation
Mar 07, 2016
MilliporeSigma Launches Global Science Education Program to Inspire Future Scientists

MilliporeSigma today announced the launch of SPARK, a global skills-based volunteer program that provides community service opportunities for its network of 19,000 employees, with a focus on science and education.

20160307
Jan 08, 2016
MilliporeSigma Donates to American Red Cross to Support Greater St. Louis Flood Victims

MilliporeSigma today announced it has donated $10,000 to the American Red Cross of the Greater St. Louis Region in support of the organization’s flood relief efforts.

20160108
Dec 16, 2015
MilliporeSigma Honored by R&D Magazine for Innovation

MilliporeSigma today announced it has received two prestigious R&D Magazine 100 awards – one for its lab water purification systems, and the other for a technology that allows researchers to investigate scientific questions they previously couldn’t address.

20151216 Water Purification,Small Molecule Pharmaceuticals,Life Science Research,Biopharmaceutical Manufacturing
Nov 18, 2015
Merck KGaA, Darmstadt, Germany, Completes Sigma-Aldrich Acquisition

Merck KGaA, Darmstadt, Germany today announced the completion of its $ 17 billion acquisition of Sigma-Aldrich, creating one of the leaders in the $ 130 billion global industry to help solve the toughest problems in life science.

20151118
Nov 20, 2015
Merck KGaA, Darmstadt, Germany Intends to Launch Innovative System for Monitoring CD4 T lymphocytes and T cells throughout Africa

Merck KGaA, Darmstadt, Germany today hosted a discussion with renowned researchers to discuss the intention to launch its innovative Muse® Auto CD4/CD4% System, a portable instrument for monitoring T cells and CD4 counts throughout Africa.

20151120 Life Science Research
Nov 18, 2015
Merck KGaA, Darmstadt, Germany Launches Innovative System for Monitoring T cells in HIV patients in Nigeria

Merck KGaA, Darmstadt, Germany today announced the launch of its innovative Muse® Auto CD4/CD4% System, a portable instrument for monitoring T cells and CD4 counts in HIV affected patients in Nigeria.

20151118 Life Science Research
Nov 09, 2015
EMD Millipore Launches Novel Cancer Stem Cell Identification Kit, Exclusively Licensed from Johns Hopkins University

EMD Millipore today introduced the new AldeRed™ ALDH Detection Kit for identifying and isolating cancer stem cells.

20151109 Life Science Research
Oct 26, 2015
MilliporeSigma Introduces Parteck® SRP 80 Excipient for Sustained-Release Oral Solid Dose Formulations

MilliporeSigma today introduced Parteck® SRP 80, a new functional excipient for oral sustained-release formulations.

20151026 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Oct 22, 2015
MilliporeSigma to Provide Provantage® End-to-End Solution for Development and Manufacture of Biosimilars under Strategic Alliance with Turgut Ilaç

MilliporeSigma today announced the Company has entered into a strategic alliance with Turgut Ilaç, a leading biosimilars company based in Turkey and will provide their Provantage® End-to-End services for development and manufacturing of biologics.

20151022 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Oct 21, 2015
MilliporeSigma Introduces Millipore Express® PHF Hydrophilic Sterilizing-Grade Filters for Fast, Efficient and Economical Buffer Filtration

MilliporeSigma today introduced Millipore Express® PHF (process protection, high-flux) hydrophilic filters for fast, efficient and economical buffer filtration.

20151021 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Sep 28, 2015
MilliporeSigma Publishes White Paper Highlighting Importance of Emerging Biotech Companies for Discovery of New Drugs During Recent Emerging Biotech Executive Summit

MilliporeSigma today announced that it has published an original white paper, recognizing the impact the emerging biotech community has on the future of healthcare.

20150928 Water Purification,Small Molecule Pharmaceuticals,Reagents Chemicals and Labware,Life Science Research,Industrial Biomonitoring,IVD/OEM Materials and Reagents,Biopharmaceutical Manufacturing,Analytics and Sample Preparation
Sep 14, 2015
MilliporeSigma Introduces Enhancements to its Emprove® Program of Pharmaceutical Raw Materials to Facilitate Risk Assessment

MilliporeSigma today introduced enhancements to its industry-leading Emprove® portfolio of pharmaceutical raw materials.

20150914 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Aug 12, 2015
MilliporeSigma Announces Charitable Contribution to Massachusetts Institute of Technology (MIT) for Development of Novel Ebola Diagnostic and Tracking Platform

MilliporeSigma today announced it is providing the Massachusetts Institute of Technology (MIT) with a $50,000 charitable contribution to support the development of a novel diagnostic and tracking platform for Ebola.

20150812
Jul 27, 2015
MilliporeSigma Adds Protein Pegylation to Portfolio of Services for Biopharmaceutical Industry through Collaboration with celares GmbH

MilliporeSigma today announced a collaboration with celares GmbH to provide pegylation services to customers developing protein-based therapeutics and biosimilars.

20150727 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jun 16, 2015
MilliporeSigma’s Additions to the MAS-100® Product Family of Microbial Air Samplers Deliver Improved Functionality for Pharmaceutical Manufacturers

MilliporeSigma today announced three additions to its MAS-100® product family.

20150616 Industrial Biomonitoring
Jun 15, 2015
MilliporeSigma Introduces the Mobius® 2000 Liter Single-Use Bioreactor with Industry-leading Design for Ease-of-Use

MilliporeSigma today introduced the Mobius® 2000 liter single-use bioreactor. The 2000 liter bioreactor joins the Mobius® stirred tank bioreactor portfolio (from 3 to 2000 liters) that provides the ultimate in flexibility, scalability, and convenience.

20150615 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jun 15, 2015
MilliporeSigma Expands Provantage® Biodevelopment Services with Addition of Provantage® Clone Generation Service

MilliporeSigma today announced expansion of its Provantage® Biodevelopment Services to include a Clone Generation Service.

20150615 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jun 02, 2015
MilliporeSigma Introduces Compaction Technology to Improve Solubility and Facilitate Handling of Cell Culture Media Used in Biopharmaceutical Production

MilliporeSigma today introduced a new technology that compacts dry powder cell culture media into granules, accelerating solubility and improving flowability and handling.

20150602 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jun 01, 2015
MilliporeSigma Congratulates Nancy Hopkins, Ph.D. of the Koch Institute for Integrative Cancer Research (MIT) as Recipient of 2015 Alice C. Evans Award

MilliporeSigma today announced that Nancy Hopkins, Ph.D., Amgen, Inc. Professor of Biology (emerita), Biology Department and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), is the recipient of the 2015 MilliporeSigma Alice C. Evans Award for Leadership in Clinical Microbiology.

20150601 Industrial Biomonitoring
Jun 01, 2015
MilliporeSigma Launches Cellvento™ CHO Cell Culture Media Platform for Optimized Cell Growth and Productivity

MilliporeSigma today announced the launch of its Cellvento™ CHO platform of cell culture media and companion feed formulations for batch, fed-batch and perfusion applications.

20150601 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
May 21, 2015
MilliporeSigma Introduces Single-Pass Tangential Flow Filtration with Pellicon® Cassettes for Increased Capacity, Recovery and Concentration

MilliporeSigma today introduced single-pass tangential flow filtration (TFF) with Pellicon® cassettes, an enhanced application of MilliporeSigma’s existing TFF technology that allows concentration of process streams without the recirculation required in traditional TFF.

20150521 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
May 21, 2015
MilliporeSigma Enters Into Agreement to Acquire Exclusive Rights to Singulex’s Ultra-Sensitive Single Molecule Counting (SMC™) Technology

MilliporeSigma and Singulex, the developer and leading provider of Single Molecule Counting (SMCTM) technology for clinical diagnostics and scientific discovery, today announced that they have entered into a definitive agreement under which MilliporeSigma will control and manage the Singulex Life Science Research business.

20150521 Life Science Research
May 06, 2015
Study Finds MilliporeSigma’s Strat-M® Synthetic Membrane Comparable to Human and Animal Skin for Permeation Studies

MilliporeSigma announced publication of a study showing that its Strat-M® synthetic membrane predicts skin permeation of chemical compounds during in vitro transdermal diffusion studies as effectively as human or animal skin.

20150506 Life Science Research
Apr 23, 2015
MilliporeSigma Introduces Magna ChIRP™ RNA Interactome Kits for the Analysis of Chromatin-Associated RNAs

MilliporeSigma today introduced Magna ChIRP™ RNA Interactome Kits, which allow researchers to more easily identify, recover and analyze regions of chromatin that interact with chromatin-associated RNAs such as long non-coding RNA (lncRNA).

20150423 Life Science Research
Feb 02, 2015
MilliporeSigma Announces Agreement with Precision Biologics, Inc. to Provide Upstream Process Development Services

MilliporeSigma today announced an agreement for providing upstream process development services for Precision Biologics, Inc., a Texas-based clinical-stage biotechnology company, to advance a preclinical monoclonal antibody.

20150202 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jan 27, 2015
MilliporeSigma Introduces New High-Performance Water Purification Systems with 24/7 Real-Time Monitoring and Remote Control

MilliporeSigma today announced the introduction of its AFS® 40E / 80E / 120E and 150E water purification systems.

20150127 Water Purification
Nov 19, 2014
MilliporeSigma Launches Kit for Analyzing NFкB Translocation by Imaging Flow Cytometry

MilliporeSigma today introduced the Amnis® NFкB Translocation kit, which allows researchers to better study the nuclear translocation of NFкB, a transcription factor that plays a central role in regulating key mammalian cell processes, including proliferation, inflammation, immune and stress responses.

20141119 Life Science Research
Oct 21, 2014
MilliporeSigma Introduces PureFlex™ Plus Single-Use Process Container Film for High-Volume Biopharmaceutical Applications

MilliporeSigma has expanded its single-use film offerings with the introduction of PureFlex™ Plus film, a robust, durable film used in the construction of Mobius® single-use process containers for biopharmaceutical manufacturing.

20141021 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Nov 06, 2014
MilliporeSigma's guava easyCyte™ 12 Flow Cytometer Offers Improved Resolution Down to 0.2 μm

MilliporeSigma offers new data demonstrating improved performance for its guava easyCyte™ 12 flow cytometer, a simple and powerful benchtop method for multicolor flow cytometry.

20141106 Life Science Research
Nov 03, 2014
MilliporeSigma’s New SNAP i.d.® 2.0 System for Immunohistochemistry Minimizes Slide Handling

MilliporeSigma has introduced the SNAP i.d.® 2.0 Protein Detection System for Immunohistochemistry (IHC), which streamlines immunohistochemistry workflows and significantly decreases slide handling time.

20141103 Life Science Research
Sep 22, 2014
Merck KGaA, Darmstadt, Germany, to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry

Merck KGaA Darmstadt, Germany, today announced that they have entered into a definitive agreement under which Merck KGaA, Darmstadt Germany, will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry.

20140922
Sep 15, 2014
MilliporeSigma Recognized for Technologically Advanced Products by R&D Magazine

MilliporeSigma announced it has received two R&D Magazine 100 Awards for innovative products released to market in 2013.

20140915 Small Molecule Pharmaceuticals,Life Science Research,Biopharmaceutical Manufacturing
Aug 28, 2014
Compact, Easy-to-Use Steritest™ Symbio Pumps from MilliporeSigma Leverage Industry Leading Technology for Improved Sterility Testing

MilliporeSigma has launched Steritest™ Symbio Pumps for easier, safer and more reliable sterility testing of pharmaceutical products in laminar flow hoods, isolators and clean rooms.

20140828 Industrial Biomonitoring
Aug 26, 2014
MilliporeSigma Expands Biomanufacturing Sciences and Training Center in Japan and Announces Opening of New Location in Tokyo

MilliporeSigma today announced the opening of a new Biomanufacturing Sciences Training Center (BSTC) facility in Tokyo.

20140826 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Aug 20, 2014
MilliporeSigma Announces Strategic Alliance on Biopharmaceutical Manufacturing with Samsung BioLogics

MilliporeSigma announced today that MilliporeSigma and Samsung BioLogics signed an MOU (Memorandum of Understanding) for a strategic alliance on the biopharmaceutical business.

20140820 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
May 05, 2014
EMD Millipore Expands Provantage® Upstream Bioproduction Services to the North American Market

EMD Millipore today announces the expansion of its upstream services into North America as part of its Provantage® Biodevelopment and Clinical Supply offering.

20140505 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Apr 09, 2014
EMD Millipore and VWR Extend Western European Distribution Agreement

EMD Millipore today announced a new non-exclusive, preferred distribution agreement for Western Europe with VWR a global provider of laboratory supplies, equipment and services.

20140409 Reagents Chemicals and Labware,Industrial Biomonitoring,Analytics and Sample Preparation
Mar 17, 2014
EMD Millipore Announces Clinical Research, Licensing and Joint Development Agreement with Sysmex Corporation

This collaboration will use EMD Millipore’s flow cytometry technology as a platform to accelerate the creation of new, more powerful diagnostic tools for research in blood disorders.

20140317 Life Science Research
Mar 10, 2014
EMD Millipore Receives Grant from Massachusetts Life Sciences Center to Collaborate with Promethera Biosciences

This is one of four grants given to Life Science companies in Massachusetts to fund international collaboration as part of MLSC’s International Collaborative Industrial Program.

20140310 Life Science Research
Feb 04, 2014
EMD Millipore Introduces DRYPOUR™ Packaging System to Minimize Caking of Pharmaceutical Raw Materials

The DRYPOUR™ packaging system minimizes caking of hygroscopic salts used in pharmaceutical manufacturing during transport and storage.

20140204 Biopharmaceutical Manufacturing,Small Molecule Pharmaceuticals
Jan 29, 2014
EMD Millipore Expands its EMPROVE® Raw Materials Portfolio to 400 Products

The portfolio includes EMPROVE® api for active pharmaceutical ingredients, EMPROVE® exp for excipients and EMPROVE® bio for biopharmaceutical materials.

20140129 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Dec 17, 2013
EMD Millipore Provides Disaster Relief to Typhoon Haiyan Victims

EMD Millipore is providing product and monetary donations to assist those severely affected by Typhoon Haiyan in the Philippines.

20131217 Industrial Biomonitoring
Oct 23, 2013
EMD Millipore Launches CpGenome Direct Prep Bisulfite Modification Kit for Simplified One-Step Conversion of Unmethylated Cytosines

By eliminating the need to isolate genomic DNA prior to performing bisulfite analysis, the kit provides a simple and reliable protocol for one-step bisulfite conversion.

20131023 Life Science Research
Nov 08, 2013
EMD Millipore Wins R&D Magazine 100 Award for its Direct Detect® Protein Quantitation System

The Direct Detect® system was recognized as one of R&D Magazine’s 100 most innovative and technologically significant products to be introduced into the marketplace.

20131108 Life Science Research
Nov 07, 2013
EMD Millipore Donates $10,000 to Environmental and Energy Study Institute in Recognition of Energy Month

The donation will specifically support EESI’s Transportation and Communities Program, which emphasizes energy efficiency and renewable energy across the transportation sector.

20131107
Oct 16, 2013
EMD Millipore to be Global Distributor for SmartRNAplex MicroRNA Profiling Assay

MicroRNA detection with SmartRNAplex requires just three steps: hybridize, label, and report.

20131016 Life Science Research
Oct 22, 2013
EMD Millipore Introduces Parteck® SLC, Silica-based Excipient for Enhanced Drug Solubility and Bioavailability

Featuring a unique pore structure, Parteck SLC for drug delivery enables loading of oral dosage forms with amorphously distributed API to the highest levels.

20131022 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Oct 22, 2013
EMD Millipore Introduces the First Online Original Manufacturer Tracking Tool

The electronic Original Manufacturer Tracking (eOMT) saves users valuable time in research and enables compliance with regulatory requirements.

20131022 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Oct 10, 2013
Beijing Higher Court Rules in Favor of EMD Millipore in Patent Infringement Case

The Court determined that RephiLe’s accused products fall into the protection scope of EMD Millipore’s patent.

20131010
Sep 12, 2013
EMD Millipore Receives Recertification of GMP Compliance for Biodevelopment Centre in Martillac, France

EMD Millipore today announced that its Biodevelopment Centre in Martillac, France, has been recertified by the French National Agency for Medicines and Health Products Safety (ANSM), the competent authority of France.

20130912 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Sep 26, 2013
EMD Millipore Accepts Stevie Awards for Direct Detect® and Muse® Products at the 2013 American Business Awards

These awards were distributed by the American Business Awards, the premier business award program in the United States - finalists were announced in June.

20130926 Life Science Research
Apr 19, 2012
EMD Millipore Live Lab Tour 2012 to Visit Science Zones in Europe

The “Live Lab,” a 60-square-meter exhibition space housed in an eye-catching coach-style vehicle, is a novel way to bring information about new technologies right to the workplace.

20120419 Water Purification
Feb 07, 2012
EMD Millipore Introduces Elix® Essential 3, 5, 10, 15 Water Purification Systems

The new systems integrate patented Elix electrodeionization (EDI) technology along with several other complementary water purification techniques.

20120207 Water Purification
Jan 25, 2012
EMD Millipore Enhances Range of Direct-Q® 3, 5, 8 Water Purification Systems

First launched in 2005, the Direct-Q systems met with immediate and continuing success

20120125 Water Purification
Feb 21, 2012
EMD Millipore Introduces AFS® 10E and AFS® 15E Water Purification Systems

The EMD Millipore AFS 10E and AFS 15E water purification systems integrate patented Elix® electrodeionization (EDI) technology along with several other complementary water purification techniques

20120221 Water Purification
Jun 19, 2012
EMD Millipore Introduces AFS® 8D and AFS® 16D Degassed Water Purification Systems

The new systems are designed to provide cost-effective, low-maintenance solutions for clinical analyzers requiring degassed clinical laboratory reagent water (CLRW).

20120619 Water Purification
May 25, 2011
EMD Millipore Introduces Bottled Water with Certified Water Quality

Water for Cell Culture and Water for Molecular Biology are produced in an ISO® 9001 / cGMP environment. The bottled water is subject to strict quality control tests.

20110525 Water Purification
Mar 08, 2011
EMD Millipore Introduces All-in-One Water Purification System for High-Volume Clinical Analyzers

The Elix Gulfstream Clinical water purification system will provide up to 100 liters per hour and 2000 liters of clinical laboratory reagent water (CLRW) daily

20110308 Water Purification
Sep 18, 2013
EMD Millipore Donates $5,000 and School Supplies for Children in Need

EMD Millipore Teams Up with the Vince Wilfork Foundation to Donate Backpacks and School Supplies to Boston-Area Students

20130918
Sep 16, 2013
EMD Millipore Named One of the Top Charitable Contributors by the Boston Business Journal

EMD Millipore Named One of the Top Charitable Contributors by the Boston Business Journal

20130916
Sep 17, 2013
EMD Millipore Introduces Novel Clarisolve Depth Filters

Novel Clarisolve Depth Filters Deliver Unmatched Speed and Efficiency for Single-Stage Clarification of Pretreated Feed Streams

20130917 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Sep 10, 2013
EMD Millipore Donates $30,000 to charity: water in Recognition of World Water Week

EMD Millipore today announced a $30,000 donation to charity: water in recognition of World Water Week.

20130910
Jul 12, 2013
EMD Millipore Opens New R&D Center, Expanding Capabilities in Bioavailability Enhancement and Oral Dosage Formulation

The center will accelerate growth of the company’s portfolio of innovative technologies and products that overcome bioavailability and formulation challenges

20130712 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jun 06, 2013
EMD Millipore Direct Detect® and Muse Products Named as Finalists in 2013 American Business Awards

The Muse Cell Analyzer provides greater accuracy and precision than manual hemocytometry or image-based automated analysis.

20130606 Life Science Research
May 20, 2013
Vince Wilfork Visits EMD Millipore’s Jaffrey, NH Manufacturing Facility and Thanks Employees for Supporting the Vince Wilfork Foundation

Since 2011, EMD Millipore has supported the Vince Wilfork Foundation and its efforts to fund critical research at several leading diabetes institutions.

20130520
Jun 12, 2013
EMD Millipore Launches PluriSTEM Human ES/iPS Medium for the Expansion of Human Embryonic and Induced Pluripotent Stem Cells

The proprietary formulation includes Activin-A, TGFβ1, and b-FGF to promote stem cell self-renewal and potent small molecule combinations to inhibit unwanted spontaneous differentiation.

20130612 Life Science Research
Jun 24, 2013
EMD Millipore Launches Cellvento CHO-200 Chemically Defined Cell Culture Medium for Consistent High Performance in Fed-Batch Mode

Cellvento CHO-200 medium and its corresponding feeds do not contain hydrolysates or components of unknown composition, resulting in very good lot-to-lot consistency.

20130624 Biopharmaceutical Manufacturing
Jul 08, 2013
EMD Millipore Awards Annual Scholarships

This year’s recipients are Emily Caron, daughter of EMD Millipore employee Roger Caron and Alexander Murphy, stepson of EMD Millipore employee Heather Sue Murphy.

20130708
Jul 10, 2013
150 Cyclists from EMD Millipore and Merck Serono Participated in 150 Mile Ride for MS

As a leading supplier of tools and technologies that support research for many chronic diseases including MS, EMD Millipore is proud to support the National Multiple Scleroses Society.

20130710
Mar 15, 2012
EMD Millipore Launches Mobius® CellReady 50 L Single-use Stirred Tank Bioreactor

This new single-use bioreactor allows biopharmaceutical manufacturers to implement robust, single-use technologies that bring their drugs to market faster, with less risk.

20120315 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 27, 2012
EMD Millipore Opens its First Lab Water Production Site in China Ming Che, a China-exclusive brand, is on the way

The opening of this lab water production facility marks another milestone for EMD Millipore in China, reflecting its long term commitment to the market.

20120227 Water Purification
May 08, 2013
EMD Millipore Leadership Recognized with Diabetes Champion Award by JDRF

Christina Shasserre was recognized for EMD Millipore’s support of JDRF, which includes serving as the chair sponsor of the annual “Walk to Cure Diabetes.”

20130508
May 10, 2013
EMD Millipore Receives Chairman’s Award from Massachusetts Governor at Associated Industries of Massachusetts Luncheon

This award recognizes a Massachusetts firm, institution or public agency of any size that has demonstrated excellence in international trade.

20130510
May 14, 2013
EMD Millipore Introduces Magna ChIP® HiSens Chromatin Immunoprecipitation Kits

These new kits enable target chromatin enrichment from both low and high amounts of input chromatin while delivering low backgrounds, high signal-to-noise ratios, and ultra-sensitive detection.

20130514 Life Science Research
May 21, 2013
EMD Millipore and PharmaCell to Develop Optimized Large-Scale Expansion and Harvesting of HepaRG® Cells Grown from Bioreactors

The companies will work together to produce protocols and methods for efficient expansion, harvest and use of HepaRG® cells in support of the BALANCE project.

20130521 Biopharmaceutical Manufacturing
Jun 25, 2012
Vincent Donovan to Lead BioPharmaceutical Process Solutions at EMD Millipore

Donovan joined Millipore Corporation in 1988 and has held numerous sales leadership roles including Senior Director, North American Field Operations, and Director of Sales.

20120625 Biopharmaceutical Manufacturing
Jun 04, 2012
EMD Millipore Demonstrates Successful Scale-up of Human Stem Cells on Microcarriers in the Mobius® CellReady 3 L Single-use Bioreactor

This new application facilitates large-scale production at up to one-third the cost per dose compared to cells grown in flat culture stacks.

20120604 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
May 16, 2012
Dana Hubbard, Head of Patents for EMD Millipore, named to Boston’s Top Rated Lawyers

This list, created by LexisNexis Matindale-Hubbell, is a peer-reviewed rating of the leading local lawyers who have reached the highest levels of ethical standards and professional excellence.

20120516
May 01, 2013
Andrew Bulpin to Assume Leadership of Process Solutions at EMD Millipore

He will assume leadership effective May 14, 2012 and be based at the company’s U.S. headquarters in Massachusetts.

20130501 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 12, 2012
EMD Millipore Adds Millistak® µPod Filter to Line of Disposable Depth Filter Systems

With the Millistak+ µPod filter, users can easily connect multiple devices in parallel or series to rapidly screen combinations of media.

20120212 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 27, 2012
EMD Millipore Partners with Charles River Laboratories for Improved Viral Clearance Studies

EMD Millipore and Charles River will collaborate to integrate the TrueSpike technology into viral clearance services provided by Charles River.

20120227 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Mar 01, 2012
EMD Millipore Introduces CellPrime Recombinant Human Lysozyme for Increased Protein Recovery From E. coli Production Systems

The increased efficiency offered by CellPrime recombinant human lysozyme, combined with high activity levels, results in a reduction of overall production costs.

20120301 Biopharmaceutical Manufacturing
Mar 12, 2012
EMD Millipore and the Centre for Commercialization of Regenerative Medicine Collaborate to Optimize Conditions for Large-scale Stem Cell Cultivation

This joint project will focus on the development of a proprietary monitoring and control methodology, enabling robust growth of adherent human pluripotent stem cells.

20120312 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Aug 07, 2012
EMD Millipore Announces Exclusive Agreement with Julphar Diabetes to Offer Non-animal Origin, Recombinant Human Insulin as Cell Culture Media Supplement

CellPrime Insulin stimulates the proliferation of cells and aids in carbohydrate metabolism, helping to ensure the long-term viability of various cell lines.

20120807 Biopharmaceutical Manufacturing
Jun 20, 2012
EMD Millipore Launches Provantage® Solutions at BIO 2012

Provantage Solutions provide greater control and increased flexibility for both small and large molecule development and manufacturing processes.

20120620 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Apr 10, 2012
Third Annual "EMD Millipore Pharma Forum” to Address Latest Developments in Pharmaceutical Raw Materials Industry

Presentations and discussions will explore the recent launch of the new excipients certification program EXCiPACT.

20120410 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jul 10, 2012
EMD Millipore Introduces Unique Lab Water E-Solution: Millitrack® Compliance

This unique fully-embedded water purification system software has been developed especially for the pharmaceutical, biotech and contract labs that follow GxP regulations.

20120710
Sep 20, 2012
EMD Millipore Announces the Opening of its State-of-the-Art GMP Bioproduction Facility in Martillac, France

The site will serve users of EMD Millipore’s Provantage Biodevelopment and Clinical Supply Solutions option that incorporates the latest technologies for upstream and downstream processes.

20120920 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Sep 12, 2012
EMD Millipore Named 53rd on the Boston Business Journal’s List of Top Charitable Contributors

“We are very proud to make the Boston Business Journal’s List of Top Charitable Contributors once again,” says Tara Duplaga, Manager of the EMD Millipore Giving Program.

20120912
Aug 30, 2012
EMD Millipore Donates $10,000 to charity: water in Recognition of World Water Week

World Water Week, held this year from August 26 to September 1, provides a forum for conversation and best practices concerning the ongoing clean water crisis in our global community.

20120830
Aug 08, 2012
EMD Millipore Extends its Innovative NovaSeptum® Sterile Sampling Offerings

This novel design protects product integrity and prevents product loss during sample collection, transport and especially during long term storage where stress release can induce leakage.

20120808 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Aug 06, 2012
EMD Millipore Launches Mobius® FlexReady Solution with Smart Flexware® Assemblies for Chromatography

The Mobius FlexReady Solution with Smart Flexware Assemblies for Chromatography is a fully-automated system designed to achieve optimum performance.

20120806 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Aug 22, 2012
Merck KGaA, Darmstadt Germany, Acquires Cell Culture Media Specialist Biochrom AG

The acquisition will strengthen EMD Millipore’s Process Solutions business unit, which provides products, services and solutions that simplify production complexity for manufacturers.

20120822 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Aug 14, 2012
EMD Millipore Launches PureGenome Kits and Reagents for Fast and Efficient Preparation of Next Generation Sequencing Libraries

PureGenome library preparation is a simple, two-step process followed by amplification using EMD Millipore’s ultra-high fidelity KOD Hot Start DNA Polymerase Mastermix.

20120814 Reagents Chemicals and Labware,Life Science Research
Jul 05, 2012
EMD Millipore Wins Prestigious R&D Magazine 100 Award

The Samplicity® Filtration system provides a higher throughput, ergonomic alternative to syringe-tip filters for the preparation of liquid chromatography samples.

20120705 Analytics and Sample Preparation,Life Science Research
May 14, 2012
EMD Millipore Muse Cell Analyzer Wins Prestigious red dot Design Award

Red dot is one of the world’s largest and most prestigious design competitions from Germany, and is one of the most sought-after quality marks for design recognition globally.

20120514 Life Science Research
Apr 17, 2012
EMD Millipore Launches Strat-M Synthetic Membrane Model for in vitro Transdermal Diffusion Studies

The synthetic membrane can be successfully used in place of human or animal skin to provide information about permeation characteristics of the compound through human skin.

20120417 Life Science Research
Apr 16, 2012
EMD Millipore Receives 2012 REBRAND 100 Global Award

The goal of EMD Millipore’s rebrand initiative was to support strategic branding during the merger and to define the brand’s positioning, vision, and mission.

20120416
Mar 21, 2012
EMD Millipore Announces Exclusive Supply and Marketing Agreement With Ventria Bioscience to Expand its CellPrime Line of Non-animal Origin Products

This product, which utilizes Ventria’s ExpressTec biomanufacturing technology, will be exclusively marketed and distributed by MilliporeSigma to its customers on a global basis.

20120321 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Sep 19, 2012
EMD Millipore and the Institute of Bioprocess Engineering and Pharmaceutical Technology to Develop Optimized Process Control and Harvesting of Stem Cells Grown from Bioreactors

This project will focus on the development required to ensure removal of microcarriers and any particulates from stem cell products grown in the Mobius® CellReady disposable bioreactor.

20120919 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Oct 18, 2012
EMD Millipore’s Process Solutions Business Unit Announces Updated 2013 Pricing For Pharm Chemical Solutions and Biopharm Process Solutions Products

The price adjustments are being driven by recent and anticipated cost increases, macroeconomic trends and inflation among other considerations.

20121018 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Oct 09, 2012
EMD Millipore Offers a Comprehensive and Growing Portfolio of Products and Technologies for Bioavailability Enhancement

This includes products for all types of dosage forms that address solubility, PK/PD modification, which must be taken into account for optimized bioavailability in the final drug.

20121009 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Oct 12, 2012
EMD Millipore Provides Grant to The Breast Cancer Research Foundation

The fund will be in the form of two grants of $250,000 each over a two-year period, and is the latest development in EMD Millipore’s two-year alliance with BCRF.

20121012
Sep 05, 2012
EMD Millipore Introduces Cellvento CHO-100, a Chemically-defined, Non-animal Origin Media for Superior Cell Growth and Productivity

The new media formulation was designed for the long-term growth of Chinese Hamster Ovary (CHO) cells to express antibodies or protein products.

20120905 Biopharmaceutical Manufacturing
Sep 18, 2012
EMD Millipore and VeriStem Technologies to Develop Purification Methods for Large-scale Stem Cell Production

Large-scale production of stem cells is necessary to enable their advancement into human clinical trials and to effectively deliver the quantities required.

20120918 Small Molecule Pharmaceuticals,Life Science Research,Biopharmaceutical Manufacturing
Sep 17, 2012
EMD Millipore Obtains Global Licensing Agreement for induced Pluripotent Stem(iPS) Cell Patent Technology with iPS Academia Japan, Inc. (AJ)

Under the agreement, EMD Millipore will continue to offer its STEMCCA™ reprogramming kits, which provide a highly efficient, reproducible method for creating iPS cells.

20120917 Life Science Research
Jan 07, 2013
EMD Millipore Launches Mobius® FlexReady Solution with Smart Flexware® Assemblies for Tangential Flow Filtration

Unlike traditional single-use processing systems, this modular system is quick and easy to set up, providing the ability to switch from TFF to Chromatography.

20130107 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Nov 15, 2012
EMD Millipore Launches Eshmuno® CPX, a Strong Cation Exchanger Optimized for High Resolution and High Productivity

Built on EMD Millipore’s proven Eshmuno resin technology, the new media offers high aggregate removal efficiency and high dynamic binding capacity, supporting highly productive downstream bioprocessing.

20121115 Biopharmaceutical Manufacturing
Nov 13, 2012
EMD Millipore Hosts Two Chromatography User Group Meetings

User Group Meetings attract global biotechnology and biopharmaceutical industry professionals, including those in chromatography R&D, process development, production management and engineering.

20121113 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Nov 01, 2012
EMD Millipore and Sistemic Collaborate to Identify Control Markers for Stem Cell Production

The two companies are jointly developing a methodology utilizing Sistemic’s microRNA marker detection capability to enable consistent growth of stem cells.

20121101 Small Molecule Pharmaceuticals,Life Science Research,Biopharmaceutical Manufacturing
Apr 30, 2013
EMD Millipore Launches OsteoMAX-XF, a Fully Defined, Xeno-free Mesenchymal Stem Cell Osteogenic Differentiation Medium

Mineralization can be detected in less than one week, whereas competing products that contain serum require approximately 21 days to produce similar levels of bone formation.

20130430 Life Science Research
Apr 23, 2013
New SIRTainty Class III HDAC Assay from EMD Millipore Used in Recent Study Demonstrating Novel Mechanism for Activation of SIRT1

Unlike conventional assays that are dependent upon a single pre-labeled fluorescently tagged substrate, the SIRTainty Class III HDAC Assay employs untagged acetylated peptide substrates.

20130423 Life Science Research
Feb 28, 2013
EMD Millipore Muse Cell Analyzer Wins Prestigious GOOD DESIGN® Award

The Chicago Athenaeum: Museum of Architecture and Design and Metropolitan Arts Press Ltd. present the Museum's annual GOOD DESIGN® Awards Program.

20130228 Life Science Research
May 02, 2013
Patent Litigation Settlement and License between EMD Millipore and W. L. Gore & Associates, Inc.

EMD Millipore announced the settlement of patent infringement disputes between EMD Millipore and W.L. Gore & Associates, Inc. in the U.S. District Court for the District of Massachusetts.

20130502 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Jan 29, 2013
Expansion of EZ-Product Family for Faster, More Efficient Bioburden Analysis and Microbial Detection in Beverages

The EZ-product family now includes the EZ-Fluo rapid detection system, a non-destructive, fluorescent staining-based system for microbial detection.

20130129 Industrial Biomonitoring
May 14, 2013
Magna ChIP® HiSens Chromatin Immunoprecipitation Kits

These new kits enable target chromatin enrichment from both low and high amounts of input chromatin while delivering low backgrounds, high signal-to-noise ratios.

20130514 Life Science Research
Mar 31, 2012
Direct Detect Biomolecular Quantitation System

A system for rapid, simplified protein quantitation exploits EMD Millipore’s membrane expertise to enable infrared-based measurement of amide bonds in protein chains.

20120331 Life Science Research